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Abstract
St. Jude Medical: Pulmonary Edema Monitoring in Pacemakers and ICDs
David Wei-Péng Chang

Pulmonary edema occurs when fluid leaks from the pulmonary
capillary network into the lung interstitium and alveoli. When the heart is
not able to pump blood to the body efficiently, fluid can back up into the
veins that take blood through the lungs to the left atrium. This then builds
up the pressure in the blood vessels and fluid is pushed into the alveoli in
the lungs. The fluid reduces normal oxygen movement through the lungs
and can cause impaired gas exchange and respiratory failure. There are
many causes of congestive heart failure that may lead to pulmonary
edema such as heart attack, any diseases of the heart that weaken or
stiffen the heart muscle, a leaking or narrowed heart valve, and sudden,
severe high blood pressure.
Pulmonary edema is a strong indicator of congestive heart failure in
patients and therefore can be used as a gauge for congestive heart
failure. One way to diagnose cardiogenic pulmonary edema constantly is
through the continuous monitoring of the transthoracic impedance
throughout the day. One method to achieve this constant monitoring is
through the use of a cardiac pacemaker or an implantable cardioverter
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defibrillator (ICD). Many patients who are at risk of heart failure have
these medical devices implanted already. In these implantable cardiac
devices, the connected cardiac leads can be utilized to continually screen
several impedance vectors for decreases in impedance in the thoracic
cavity. A pacemaker or ICD that implements Pulmonary Edema
Monitoring is designed to continuously monitor these impedance vectors
and alert the patient to seek medical attention. This thesis will discuss
the implementation of Pulmonary Edema Monitoring via screening of
multiple impedance vectors in a pacemaker or implantable cardioverter
defibrillator and the effectiveness of this monitoring method. Furthermore,
the design, implementation, and testing of this feature will be explored in
greater detail.

Keywords: St Jude Medical, Implantable Cardioverter Defibrillators,
Pacemakers, Medical Devices, Pulmonary Edema, Pulmonary Oedema,
Congestive Heart Failure, Intrathoracic Impedance Monitoring.
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Background and Clinical Significance

Heart failure
Heart failure (HF) is widely known as the leading cause of death for both
men and women in the United States. Approximately 600,000 people die of
heart disease in the United States every year making the early detection and
indication of heart failure a critical need [1]. Heart disease can be caused by
many conditions such as coronary artery disease, heart attack, high blood
pressure (hypertension), faulty heart valves, damage to the heart muscle
(cardiomyopathy), myocarditis, heart defects (congenital heart defects), and
abnormal heart rhythms. Figure 1 displays the significant increase in heart
disease in men and women as they grow older. The percentage of men who
report heart disease grows from just under 5% in the 18-44 year age range to
approximately 45% in the 75 year and older age range. The percentage of
women who report heart disease grows from just under 5% in the 18-44 year age
range to approximately 30% in the 75 year and older age range.
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Figure 1: Respondent-reported lifetime heart disease prevalence among adults 18 years and over, by
sex and age: United States, 1999-2009 [2]

In addition, major heart failure events result in hospitalization with clinical
manifestations of cardiogenic pulmonary edema including lab work, imaging
chest x-rays (used to analyze pleural effusion and increased vascular
congestion), echocardiograms, and invasive hemodynamic monitoring. Major
heart failure events can be confirmed by imaging and invasive monitoring and
therapy. These are all costly procedures to perform and are sometimes invasive
to the patient. The costs associated with heart failure amounted to an
astonishing $29 billion in medical costs in 2004 [3]. A decreased frequency of
hospitalization improves patients’ quality of life and may improve patient survival.
For these reasons, heart failure is widely studied and monitored closely in
patients at risk of heart failure. Utilizing pulmonary edema as an indicator that
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heart failure is a potential threat in the immediate future is a useful way of alerting
patients to life threatening conditions before they occur.

Pulmonary Edema (or Pulmonary Oedema)
Pulmonary edema (PE) has several causes, such as lung infections,
exposure to toxins, kidney disease, adverse drug reactions, smoke inhalation,
acute respiratory distress syndrome (ARDS), or high altitude exposure.
Congestive heart failure (CHF) is an imbalance in pump function in which the
heart fails to maintain appropriate blood circulation. The severest form of CHF is
cardiogenic pulmonary edema (PE).
A normal heart is composed of two upper chambers, called atria, and two
lower chambers, called ventricles. The atria receive incoming blood and pump
the blood into the ventricles. The ventricles are the more muscular chambers
that pump the blood out of the heart. Here in the heart, deoxygenated blood from
the entire body flows into the right atrium and then is passed into the right
ventricle. The right ventricle then pumps the blood through the pulmonary
arteries to the lungs. In the lungs, the blood will release carbon dioxide and pick
up oxygen. The oxygen-rich blood returns to left atrium of the heart through the
pulmonary veins and then is passed to the left ventricle. From here, the blood is
pumped out of the left ventricle through the aorta into the entire body.
In a heart where pulmonary edema develops, the imbalance in pump
function causes an increase in lung fluid secondary to leakage from pulmonary
capillaries into the interstitium and alveoli of the lungs. This fluid buildup in the
3

alveoli makes it difficult to breathe, leads to impaired oxygen and carbon dioxide
gas exchange, and may cause respiratory failure. As seen in Figure 2, clear
alveoli allow for the constant flow of oxygen and carbon dioxide through the
lungs. In the case of pulmonary edema, the fluid buildup takes away from the
alveoli surface area and disrupts the gas exchange of oxygen and carbon
dioxide.

Figure 2: Fluid may build up in the alveoli or leak into the tissues around the bronchioles. [4]

This thesis will focus on heart-related cardiac pulmonary edema. Cardiac
pulmonary edema arises when a diseased or overworked left ventricle is not able
to pump out enough of the blood it receives from the lungs. As a result, pressure
increases inside the left atrium and then in the veins and capillaries in the lungs.
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This results in another imbalance of Starling forces in the lungs and then causes
fluid to be pushed through the capillary walls into the air sacs. When fluid builds
up in the chest cavity, impedance decreases. This impedance decrease can be
measured by pacemaker or ICD leads. Pulmonary edema is a serious condition
and can cause death in as little as 60 minutes if left untreated. Figure 3 shows
the progression of congestive heart failure and pulmonary edema as previously
described.

Figure 3: Pulmonary and Cardiac Edema progression. [5]

Pacemakers and Implantable Cardioverter Defibrillators (ICDs)
Pacemakers are small pacing pulse generators that are implanted under
the skin, most often just under the collarbone. One or two lead wires will connect
5

the heart muscle to the pulse generator. These pacemakers then use leads that
are directly implanted into the heart to send electrical signals to start or regulate
a heart rhythm. A pacemaker may be used to replace the functionality of a
heart’s natural pacemaker (the SA node) that is no longer functioning properly
and has developed an abnormal heart rate or rhythm or in the case where the
electrical pathways of the heart are blocked.
Implantable cardioverter defibrillators (ICDs) are very similar to
pacemakers, but have an extra shocking capability. ICDs are capable of
providing two levels of electrical energy to the heart: a low energy shock that can
depolarize a heart causing it to beat, and a high energy shock that is delivered
only if an arrhythmia is so severe that the heart is quivering instead of pumping
or beating efficiently. In addition to all of the components that make up a
pacemaker, the ICD system also contain a pulse generator and extra leads to
deliver the high energy shock.
The most common method for implanting one of these medical devices is
through the endocardial (transvenous) approach. In this method a local
anesthetic is given to numb the implant area. An incision is made in the upper
chest region where the leads and pacemaker are inserted. These leads are
inserted through the incision made in the chest and the subclavian vein and are
then guided to the appropriate chamber of the heart with the aid of a fluoroscopy
machine. The lead tip is lodged in and attached to the heart muscle, while the
other end of the lead that is attached to the pacemaker or ICD is coiled around
and placed in a pocket created under the skin in the upper chest.
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Figure 4 shows both an ICD and pacemaker implant in a patient and how
each is set up inside the patient. Figure A of Figure 4 shows an implantable
cardioverter defibrillator implanted in the upper chest of the patient. Figure B of
Figure 4 shows a pacemaker implanted in the upper chest. For each device, the
wires with electrodes on the ends are inserted into the heart through the
subclavian vein in the upper chest as previously described [6].

Figure 4: Placement of ICDs and pacemakers in the upper chest of patients [6].

With the use of up to six vectors, the pacemaker and ICDs can be used to
take impedances across the intrathoracic cavity. The different lead
configurations allow for these medical devices to measure impedances across
different impedance vectors. By observing these impedances, these medical
devices can detect when there is fluid buildup and thus be utilized to alert the
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patient of potential heart failure. Moreover, since many patients who are at risk
of heart failure already have pacemakers or ICDs and the expanded capability of
monitoring for pulmonary edema becomes a very useful feature to add on.
These devices could be used to monitor impedance automatically and
periodically. Figure 5 depicts a high level concept of the use of a pacemaker or
ICD and their leads to take impedances in the thoracic cavity. This will aid in the
monitoring of impedance drops due to fluid buildup in the chest region [7].

Figure 5: A high level depiction of a pacemaker or ICD taking an impedance measurement. [7]

A prospective study was performed with 34 patients with New York Heart
Association class III or IV heart failure symptoms who were followed up for a
8

length of two years for heart failure hospitalization [8]. During heart failure
hospitalization, most patients underwent invasive right-sided heart catheterization
that enabled correlation of acute hemodynamic and impedance changes. Once
treatment of heart failure was initiated, impedance increased and correlated well
with decreases in pulmonary capillary wedge pressure and net fluid loss. With a
threshold value of 60 Ω-days, sensitivity to predict heart failure hospitalization
was 76.9%, with 1.5 false positive readings per patient-year. Early warning
criteria were met 13.4 ± 6.2 days (5 to 22 days) before hospitalization [8]. In a
larger prospective study, a similar pulmonary edema monitoring algorithm in
pacemakers and ICDs was used in patients who underwent biventricular ICD
implantation. The end point of that study was deterioration of heart failure on the
basis of clinical assessment. Patients were notified by an audible alert when the
fluid index threshold was crossed and were examined in an outpatient clinic for
further evaluation. Data from 373 subjects were analyzed and showed that the
algorithm had a 60% sensitivity (with 95% confidence interval 46% to 73%) factor
and a positive predictive value of 60% (with 95% confidence interval 46% to
73%) to predict heart failure events within at least 2 weeks [9].
Another prospective single-center study with 115 patients that had
congestive heart failure showed that 67% of alerts were false-positives if the fluid
index threshold level was left at nominal settings (60 Ω-days). Analysis of the
data suggested that perhaps a higher fluid index threshold level should be used
(100 to 120 Ω-days) to enhance specificity and maintain reasonable sensitivity
(60% and 73%, respectively) [10]. Thus, the limitations of this system remain its
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relatively low sensitivity and specificity. On the other hand, interpretation of
false-positive alerts is not straightforward, because these alerts may identify
subclinical heart failure exacerbation or other clinically important problems,
including pneumonia or exacerbation of chronic obstructive pulmonary disease.
The question of whether clinical outcome can be improved by early intervention
based on changes in thoracic impedance is currently being investigated in large
multicenter trials [11]. These studies also display that it is conceivable that
impedance measurements from other leads or a combination of leads may yield
improved results. There are promising experimental data to suggest that the
addition of a left ventricular lead to the measurement vector could enhance
specificity [12].
Figure 6 further depicts the results of this study and how a pulmonary
edema monitoring algorithm is beneficial to patients. The graphs in Figure 6
depict thoracic impedance measurements in a heart failure patient utilizing
Medtronic’s OptiVol algorithm. The fluid status trend was obtained from a patient
with severe heart failure and frequent heart failure exacerbations over a 12month period. The top graph shows a decrease of daily impedance value below
reference summed and expressed as fluid index. The bottom graph shows
variations of daily impedance measurements in the black line and reference
impedance values in the gray line. When the patient was found to have
worsened heart failure in the chronic heart failure clinic at point A, diuretic drugs
were increased. He remained clinically stable until June 2009 at point B, when
he was admitted to an outside hospital for fluid overload. He decompensated
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again at point C, but responded to outpatient diuretic drugs. More recently at
point D, he was found to have a 6-pound weight gain. Decline of transthoracic
impedance was evident at the time of decompensation, with rebound after
diuresis. In this patient, setting the fluid index threshold to 80 to 100 Ω-days
would likely be specific and sensitive enough to warn against impending
exacerbations of heart failure [8].

Figure 6: These graphs depict thoracic impedance measurements in a heart failure patient [8].
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Objectives

Project Objective
The main objective of this thesis is to implement an algorithm for
pacemakers and ICDs that will automatically and periodically monitor the thoracic
cavity for drops in impedance indicating possible pulmonary edema. The
implementation will be based on a wealth of research done by St. Jude Medical
and other research papers and then outlined here. Constantly examining
electrical impedance measurements across the lungs, these implanted medical
devices can detect fluid in the lungs and early signs of cardiac failure. Long term
monitoring of PE using impedance measurements can provide an early warning
of fluid volume changes in the body. These changes can be detected hours or
days prior to hospital admission so that medical intervention can occur before
symptoms reach a critical level.
The theory is that as fluid builds up in the lungs the impedance drops.
The pulmonary edema monitoring algorithm can be on or off and will utilize five to
six vectors across pacing and shocking leads. Furthermore, the feature can be
programmed to monitor the patient at several different programmable, periodic
time intervals. This allows the physician to allocate more or fewer resources to
monitor the status of fluid levels in the thoracic cavity.
The ultimate goal of the PE impedance algorithm is to be able to predict
when a congestive heart failure is about to occur. A device based algorithm that
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could instruct the patient or physician to intervene early, before symptoms have
developed, could avoid the need for hospitalization.

Project Requirements
The main objectives of this thesis are to describe a method of:
1. Automatically and periodically monitoring for decrease in impedance that
might indicate an early onset of congestive heart failure.
2. Measuring impedance accurately across the thoracic cavity for fluid
fluctuations. An average sensitivity of 50% or higher is desired.
3. Minimizing the amount of false positives in the algorithm. A false
excursion rate (FER) of less than 1 false positive per year is desired.
4. Storing long and short term averages as a reference point to indicate
whether impedance is decreasing.
5. Alerting the patient of potential congestive heart failure when the
pacemaker or ICD determines a decline in impedance relative to long and
short term averages.

Project Theory
Body fluids are good conductors of electricity. With this property,
pacemakers and ICDs can use impedance checks to give an indication of how
much fluid is built up in the thoracic cavity. Monitoring this thoracic impedance
allows a pacemaker or ICD to determine if there is an increase in fluid in the
lungs if there is a decrease in impedance. Monitoring will be accomplished by
13

using up to six impedance vectors across pacemaker and ICD electrode points.
A long term and short term average will be used as a reference for decreases in
impedance. Through these checks, these implanted medical devices will be able
to alert the patient to the danger of congestive heart failure in the near future.
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Design and Implementation

Overview of Impedance Based Monitoring
Impedance is constantly changing when measured across the chest
between a pacing lead and pulse generator. The rapid changes in impedance
are related to the cardiac and respiratory cycles as more or less blood or air fills
the tissue between the monitoring electrodes. Less dynamic changes are seen
when fluid accumulates in lung tissue. However, as pulmonary edema develops
and builds up fluid, conductance improves causing a decline in impedance in the
thoracic cavity. Therefore, the temporal changes and adequate filtering of the
impedance signal not only allow the assessment of cardiac contractility or minute
ventilation, but may also serve as a measure of changing fluid status.
This theory has been applied in clinical practice and impedance vectors
are utilized in many pacemakers and ICDs. In one of the original studies using
an ICD lead implanted in the RV apex, impedance was measured periodically
between the RV ICD coil and left pectoral pulse generator with the minute
ventilation sensor [8]. Constant current was applied between the electrodes with
a measurement frequency of 16 Hz. Measurements were averaged over a 2
minute period, and multiple samples were acquired during the day. A special
algorithm was designed that plotted a slow-moving average of daily impedance
values. Daily impedances were then compared against the moving average, and
the difference was expressed as a fluid index. As pulmonary edema develops,
daily impedance values decline and move away from the average values. Once
15

the cumulative difference between the daily measurement and reference value
reaches a programmable threshold, the detection criterion is met and a warning
is delivered to the patient [13].

Fluid Index
The main aspects of the algorithm are contained in the moving average
integral (MA), the negative trend, and short and long term averages. These
portions of the algorithm are based on the assumption that the impedance
decreases when the patient’s heart condition worsens due to fluid accumulation
in the body. All portions of this algorithm will be continuously running and has a
number of programmable parameters, described in Table 1.
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Parameter name

Explanation

Investigated values

Long Average

The length of the long term average

7, 12, 14, 21 and 28 days

Short Average

The length of the short term average

16 - 64 hours with a 4
hours incremental step

Hours Until Reset

The number of continuous hours the short

4 - 52 hours with a 4 hours

average has to be above or equal to the

incremental step

long average for the fluid index to be reset
Vector

Threshold

Which impedance signal or signals should

63 possible combinations

be used when deriving the Fluid Index

between all the electrodes.

The Fluid Index threshold by which a

Depends on the Fluid

detection is made when the Fluid Index >=

Index size.

threshold
Time of day

When, during the day, the impedance

Entire day data, afternoon

values are measured. For example can be

data (12PM – 6PM), night

00-24, 08-22 (day time), 22-08 (night time).

time data (12AM – 5AM)

Table 1: Parameter description used by all algorithms and what values were investigated.

The pulmonary edema monitoring algorithm works when it chooses one or
more impedance signals and then calculating and resetting the Fluid Index based
on those signals. This Fluid Index is compared against a programmable
threshold. If the Fluid Index exceeds the threshold for more than 24 hours, then
detection (excursion) is made. This is also illustrated in Figure 7. The first step
of the algorithm is to measure the impedance vectors and then add together the
combined impedance weights. From here the conductance and Fluid Index are
calculated and then compared against the Fluid Index threshold.
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Figure 7: This shows a high level diagram for the fluid index algorithm. [14]

The calculation of the Fluid Index is shown in detail in Figure 8. The flow
chart describes the method used to calculate the Fluid Index. When the short
term average is smaller than the long term average (also called the reference
value), a temporary variable (temp) is calculated. This is implemented using
short term sum and long term sum. The value of the temporary variable is then
weighted with the time from the previous impedance sample, and added to the
Fluid Index. Fluid Index cannot be negative in value. Additionally, the Fluid
Index is reset if the short average is greater than or equal to the long average for
more than Hours Until Reset consecutive hours. [14]

18

Figure 8: This is the flow chart that describes the method used to calculate the Fluid Index.
[Removed by SJM Legal]
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Impedance vectors
Impedance measurements are taken regularly at programmable intervals.
The measurements will take 2 minutes for all 6 vectors and is conducted at a 16
Hz frequency with the electrodes. Since the impedance signals from each
different vector vary in amplitude and variance, weighted averaging has been
used to add vectors together. The weighting factors are derived from the
average and standard deviation of the impedance signals in the pulmonary
edema monitoring feasibility study. These values are shown in Table 2 [14].

Average in data

RV coil –

LVr –

RVr –

LVr –

RAr –

RVr –

case

RAr

LVr

case

case

case

58.95 Ω

605.91 Ω

563.28 Ω

396.60 Ω

287.59 Ω

249.09 Ω

4.76 Ω

39.97 Ω

39.72 Ω

35.61 Ω

17.14 Ω

16.22 Ω

Standard
deviation in data
Offset for mixing

58.42

606.44

564.28

395.65

287.55

248.63

4

32

32

32

16

16

Scale factor for
mixing
Table 2: This is a table of coefficients for weighting and adding vectors together. [14]

The formula used for adding vectors is:
N

Z o,i  offset i

i 1

scale _ factori

Zs  (

 32  640)

In this formula, N is the number of used vectors, Zs is the mixed impedance
signal, Zo,i is the original impedance data for impedance vector i, offseti and
scaled_factori are the offset and scale factor for vector i, the current vector of
20

choice. The constant offset of 640 Ω is the constant value chosen to make the
combined impedance a positive value, and the constant scaling factor of 32 Ω is
chosen so that the scaled vector resembles a real vector. In the calculated
average and standard deviations, the standard deviation is approximately 5% of
the average for all vectors. Therefore, taking 5% of 640 Ω yield 32 Ω. [14]

As an example of utilizing this algorithm, when the vectors RV coil to Case
and RVr to Case are to be mixed, the formula will be:

Zs  (

Zo, RVcoil case  58.42
4

 32  640)  (

Zo, RVr case  248.63
16

 32  640)

If only a single vector is to be used, no scaling would have to be
accounted for. If a scaling factor is applied to the impedance signals as well as
to the thresholds (apart from the Negative Trend algorithm), the algorithm output
would be identical. Thus, it is possible to change the scale factors by replacing
them by shift operations to avoid division and keep resolution if the same scaling
is applied to the thresholds as well (apart from the Negative Trend algorithm)
[14].
Since the Negative Trend algorithm only counts the number of days the
impedance is dropping, neither a scale factor nor an offset applied to the signals
will have an effect on the threshold. This simplifies the calculations even further.
Consequently for the Negative Trend algorithm, the example above could be
reduced to:

Z s ,changed_ for _ NT  8  Z o, RVcoil case  2  Z o, RVr case

21

Moving Average Integral
The moving average (MA) integral algorithm integrates the difference
between the short term and long term averages when the impedance is dropping.
This integral constitutes the Fluid Index and therefore the algorithm takes both
the size of the impedance drop and the length of the drop into account. In the
case where the short term average is greater than or equal to the long term
average for a short period of time, the short term average is less than Hours Until
Reset hours, the difference will be negative and the Fluid Index will decrease.
Furthermore, a limit is set so the Fluid Index can never be below zero. However,
if the short term average has increased for more than Hours Until Reset hours in
a row, the Fluid Index is reset to zero. The short term and long term averages
are calculated by taking the average of the impedance signal measured in the
previous Short Average or Long Average days, respectively [14].

Negative Trend
The Negative Trend algorithm is a simple version of the above algorithms
which simply counts the time the impedance has been dropping. The size of the
drop is not important. If the short term impedance average is less than the long
term average, the Fluid Index is increased. If the short term average is greater
than or equal to the long term average for shorter periods of time (shorter than
Hours Until Reset hours), the Fluid Index is decreased. However, the Fluid Index
never can be below zero. If the short term average has been greater than or
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equal to the long term average for more than Hours Until Reset hours
continuously, the index is reset to zero.
An example of how this algorithm works is shown in Figure 9. From top to
bottom panels in Figure 9: normalized impedance (combined vectors), short
average (blue), and long average (red); patient symptoms; Fluid Index (blue) with
a threshold (dashed line); excursions (black) & HF events (red). In this figure,
the excursion is a TP. The very first heart failure event falls in the lead
maturation period so that it is not detectable [14].

Normalized impedance

Impedance and fluid index for patient 504 (418120)

* Vectors: RVc-Case + LVr-RAr +
RVr-Case
* Signal: Impedance
* Time of day: 0 to 24
* Algorithm: Negative trend 2
* Long average: 14 days
* Short average: 24 hours
* #hours to reset: 8 hours
* Threshold: 12.1096

750

700
650

Normalized impedance
Short term average
Long term average

600
12/01

01/01

02/01

Symptoms
Fluid index
Negative trend 2 (days)

03/01

04/01

05/01

06/01

11111 111111111111
222 22222222222222
333
44 444444444444
55 5 5
5555
66666666666666666666666
7777777777777
8 88
8888 8

1 = tired
2 = short of breath
3 = extra pillow s
4 = aw akened
5 = night cough
6 = pedal edema
7 = extra pill
8 = called doctor

20
sensitivity = 100%
FER = 3.1349 events/year
PEFDR = 90.3295%

10

PPV = 50%
NEP = 50%
NER = 3.1349 events/year
MEP = 0%

0
TP

Yes

FP

No
Major
Minor
No HF
12/01

01/01

02/01

03/01
Time (mm/dd)

04/01

05/01

06/01

Figure 9: An example of Fluid Index (Negative Trend) for HF detection [14].
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Patient Specific Threshold
The majority of analyses for the algorithm were completed with a fixed
threshold for all patients. However, with patient specific threshold, further
improvement could be achieved. Patient specific threshold was evaluated based
on cost saving. For example, if a threshold other than the nominal for the
particular patient could result in higher cost savings, the particular threshold
value with optimized cost saving was determined as the specific threshold for
that patient. Using equal steps (of 0.1 day) between 10 and 20 days (this range
was tested and found to be adequate to cover reasonable changes in the
threshold) for threshold, the optimal threshold for the majority of patients stayed
at the nominal threshold while optimizing threshold for the remaining patients
could achieve better sensitivity and/or false excursion rate (FER) as shown in
figures 10 and 11. [14]
In figure 10, patient specific threshold histogram that gives optimal
performance for cardiac resynchronization therapy defibrillator (or CRT-D) is
shown. 53 out of 61 patients (87%) have optimal performance at the nominal
threshold, and 8 (13%) benefit from changing the threshold. Sensitivity remains
the same (71.4%) and FER is improved from 0.56 to 0.14 with patient specific
threshold.
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Figure 10: Patient specific threshold histogram that gives optimal performance for cardiac

resynchronization therapy defibrillator (or CRT-D).

In Figure 11, patient specific threshold histogram that gives optimal
performance for an ICD is shown. 48 out of 61 patients (79%) have optimal
performance at the nominal threshold, and 13 (21%) benefit from changing the
threshold. Sensitivity is improved from 61.9% to 76.2% and FER is improved
from 0.63 to 0.21 with patient specific threshold.
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Figure 11: Patient specific threshold histogram that gives optimal performance for an ICD.

In reality, when one has programmable threshold values to accommodate
specific patient needs, implementation would not be in fine steps of 0.1 day but
rather coarse steps of 1 day (12 samples) except for the nominal and adjacent
values, which would be rounded to the closest integer number of samples to
achieve best performance in terms of cost saving. For example, a non-integer
day of threshold may be chosen to better incorporate most patients to have
specific threshold change needed in fine steps. With coarse steps, sensitivity
and FER keep the same improvement as with fine steps except for FER for ICD,
which is 0.24 instead of 0.21. The actual threshold (displayed both in days and
number of samples) and the displayed threshold to the user on the programmer
(displayed in days) are shown in the tables below. In these tables only the
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nominal threshold and the two adjacent thresholds have different actual and
displayed values.

CRT-D
Displayed threshold in

Actual threshold in days (# of

days

samples)
10

10 (120)

11

11 (132)

12

12 (144)

13

13 (156)

14

13.67 (164) – nominal

15

14.7 (176)

16

16 (192)

17

17 (204)

18

18 (216)

19

19 (228)

20

20 (240)

Table 3: This table shows the displayed and actual programmable thresholds in coarse steps for a
CRT-D device.
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ICD
Displayed threshold in

Actual threshold in days (# of

days

samples)
10

10 (120)

11

11 (132)

12

11.7 (141)

13

12.75 (153) – nominal

14

13.9 (167)

15

15 (180)

16

16 (192)

17

17 (204)

18

18 (216)

19

19 (228)

20

20 (240)

Table 4: This table shows the displayed and actual programmable thresholds in coarse steps for an
ICD device.

Patient Alert
When the medical device confirms a decrease in the impedance in the
intrathoracic cavity, the device shall trigger a clinical alert to be viewed by the
doctor and a patient alert that will indicate to the patient that they need to see a
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doctor immediately. The patient alert will signal the patient via a 10 second
vibrating notification from the medical device utilizing a vibrating motor. A
second vibrating signal will occur 30 seconds after the first alert as a confirmation
of the alert to the patient. After the initial pair of alerts, the device will continue to
alert the patient once every hour until the patient notification alert is cleared by a
physician. This alert will serve to constantly warn the patient of a life threatening
condition that is imminent.
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Results

Algorithm Optimization
The results from a study performed by St. Jude Medical staff consisting of
data on the combined pulmonary edema monitoring algorithms from June 2008
are shown below. Table 5 shows the settings that generate the best results
according to the study discussed above for the different algorithm types [14]. In
Table 5, the results show the optimal settings for the two different algorithm types
and the performance of these in terms of sensitivity, false excursion rate (FER),
and percent of event free duration spent in resolution (PEFDR). Both parts of
the algorithms show a sensitivity value of higher than 50%. When looking at
FER, the negative trend algorithm falls below 1 false positive per year, while the
moving average algorithm is higher than the allowed 1 false positive per year.
This shows that the use of the moving average by itself is not sufficient to fulfill
the project goals. However, the negative trend in conjunction with the moving
average fulfills the project requirements set out in this thesis. However, the
moving average algorithm may not be sufficient to meet the project requirements
and cannot be used individually without the negative trend algorithm.
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Algorithm settings

Results

Lon
g

Short

Hours

Time

Algorithm
Vector

Ter

Term

Until

Sensitivit

d

y

of

name
m

FER
Threshol

Avg

Reset

day

24 h

8h

00-24

(FP/year

PEFDR

)

Avg
RVc-Case
Negative

14
+ LVr-RAr

Trend

12.1096

days

79 %

0.84

98 %

93 %

3.75

92 %

days

+ RVr-Case
LVr-RAr +
MA

RVr-LVr +

14

100.8626
24 h

Integral

LVr-Case +

8h

00-24
Ω*days

days

RVr-Case
Table 5: This table shows the optimal settings for the two algorithms [14].

The results for the negative trend algorithm for single impedance vector
used were also obtained and displayed in Table 6. Table 6 displays the
algorithm and algorithm settings matched with the appropriate the results
associated with each configuration. Each vector shows a sensitivity of at least
71% or higher. However, the FER was far too high with vector yielding a result
greater than 1.
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Algorithm settings

Results

Long

Short

Hours

Time

Term

Term

Until

of

Algorithm

FER
Vector

Threshold

Sensitivity

name
Avg
Negative

PEFDR
(FP/year)

RVc-

Trend

Case

Negative

LVrRAr

Negative

RVr-

Reset

day

48 h

8h

00-24

21

12.3188

days

71 %

1.3692

97 %

93 %

4.81

94 %

79 %

2.46

95 %

79 %

2.46

92 %

100 %

9.05

71 %

86 %

3.27

91 %

days
5.5813

7 days
Trend

Avg

24 h

8h

00-24
days

14

9.7796
24 h

Trend

LVr

days

Negative

LVr-

14

Case

days

Negative

RAr-

21

11.7908

Case

days

Negative

RVr-

21

Trend

Case

days

48 h

00-24
days
5.5432

48 h
Trend

00-24
days

48 h
Trend

8h

48 h

00-24
days

24 h

8h

00-24

9.875 days

Table 6: This table shows the optimal settings and performance for each of the six single vectors for
the Negative Trend algorithm. [14]

Table 7 shows the performance of the algorithm for ICD and CRT-D
devices when combining vectors together [14]. Patients with bad vectors and
patients with non-cardiac events were also included in the study. The algorithm
sensitivity decreases by approximately 10% when comparing to the performance
from a single vector. However, the overall performance remains above 50%
sensitivity and FER of less than 1 FP/yr. A negligible difference of 0.04 false
positives per year for FER and 0.1 % for PEFDR is observed between the two
devices. This shows that both types of devices are reliable when utilizing a
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combination of two vectors at a time to determine impedance decreases. These
results support the results shown in Table 5 as well.

Algorithm Settings
Device

Vector

Type

CRT-D

RVc-Case

Results

Long

Short

Hours

Thresh

Sensitivit

FER

PEFD

Term

Term

Until

old

y

(FP/yr)

R (%)

Avg (hr)

Avg (hr)

Reset

(days)

288

48

20

13.67

71.4

0.56

98.6

336

28

8

12.75

61.9

0.6

98.5

+ LVrCase
ICD

RVc-Case
+ RVrCase

Table 7: This table shows the optimal settings and performance for different device types for the
Negative Trend algorithm. [14]

Lead Type
The study performed by St Jude Medical staff also detailed the lead types
with the impedance range used. The results display which pacemaker or ICD
lead would yield the best results for the use of this algorithm. St. Jude Medical
QuickSite and QuickFlex leads were used in this study. Combining US and nonUS patient data, there are a total of 86 patients implanted with QuickSite LV lead,
two of which have saturated and invalid LVr-Can impedance values. There are a
total of 7 patients implanted with QuickFlex lead, two of which have high LVr-Can
impedance values and a significant number of saturated samples. However,
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impedance of one of these patients recovered and became usable and valid. In
Table 5, it shows that 5 out of the 7 QuickFlex leads showed impedance in the
normal range as compared to QuickSite leads. [14]

Point ID

With saturated

Z LVr_Can at the end of

samples?

record

Lead

1603

QuickSite

Yes

Saturated, > 750 ohm

5303

QuickSite

Yes

Saturated, > 750 ohm

205

QuickFlex

No

OK, ~ 500 ohm

301

QuickFlex

No

OK, ~ 475 ohm

302

QuickFlex

No

OK, ~ 300 ohm

402

QuickFlex

No

OK, ~ 400 ohm

2601

QuickFlex

Yes

OK, ~ 600 ohm

2602

QuickFlex

No

OK, ~ 525 ohm

2705

QuickFlex

Yes

Saturated, > 750 ohm

Table 8: This table shows the lead types with the impedance range used for US and outside of the
US patients. [14]
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Discussion

Strengths
There are several strengths to this approach of pulmonary edema
monitoring. The first and foremost important benefit of a pacemaker and ICD
based algorithm is that many patients at risk of heart failure already have these
devices implanted. Since these medical devices are already implanted, it allows
for expansion of use without the addition of other devices, surgery, or costly
training. It is easy to see that a simple algorithm update can add to the additional
usefulness of patient monitoring.
Additionally, pacemakers and ICDs have a five to ten year battery life [15].
This assures that pulmonary edema monitoring will be present during the time
that these devices are implanted and operational. Since the algorithm is not
always on, the monitoring system would cost little battery life as well.

Weaknesses
One of the weaknesses of this algorithm is that any complications arise
from the implant and lead dislodgement would be difficult to troubleshoot. Once
implanted, it is difficult to reach the device and leads again to readjust the
system. Leads cannot be easily removed or repositioned without another costly
surgery. If either of these conditions were to occur, the pulmonary edema
monitoring system would not be able to provide accurate feedback.
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Furthermore, while the battery life is long at five to ten years as previously
discussed, the negative aspect of this is that it would require another procedure
to implant a replacement device when the battery is depleted. The surgery and
additional device does add a significant cost to the patient every five to ten years.
Since patients with this condition are usually frail, it is optimal to minimize
operations and medical procedures performed on them. Any form of hardware
update to this system would be cost inefficient or impossible without another
device implant. Software updates are easier and would only require a trip to the
doctor’s office.
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Conclusion and Future Work

Conclusion
The implementation of the pulmonary edema monitoring algorithm is a
large, successful step towards early detection of congestive heart failure. The
results show that this algorithm was successful in reaching the project objectives
by fulfilling the requirements set out in this thesis. The combination of the
negative trend and moving average algorithms allow the pacemaker and ICD to
automatically and periodically monitor for a decrease in impedance based on the
programmed parameters set. A sensitivity of 50% of higher was reached in all
devices used. The number of false positives per year was limited to less than 1
per year. The use of long term and short term averages were used as a
reference point for the moving average algorithm. Finally, the indication of any of
these issues would trigger an alert to warn the patient of the potential life
threatening condition.
This thesis shows that the objectives set out for pacemakers and ICDs
has been accomplished. These pacemaker and ICD systems can be used to
monitor the patient’s fluid levels and therefore detect the onset of congestive
heart failure. Utilizing impedance checks along with a short and long term slope
comparison, these medical devices can check for fluid buildup accurately and
constantly. Being able to check the patient’s status constantly, periodically, and
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automatically, pacemakers and ICDs provide an added safety measure to their
original intent of pacing and shocking the heart.

Future Work
This algorithm is promising technology to use in the constant monitoring
and status of congestive heart failure. However, there are a few other
technologies or algorithms that could enhance this technology.
One possible enhancement is the implementation of additional electrodes
that would give the opportunity to sense from more locations for a more accurate
reading. At times when leads become dislodged from the heart, additional
electrodes would provide a potential backup extra vector to replace the one that
was lost due to dislodgement. Additional vectors would also give the benefit of
having a more precise way of measuring fluid in the chest cavity.
Another enhancement is expanding the algorithm to include cardiogenic
impedances in reference to the thoracic impedance currently monitored. The
addition of this trend with the thoracic impedance allows for a determination of
whether the thoracic cavity of the patient generally has too much or too little fluid.
This added algorithm change would give another measurement to improve the
precision of detecting fluid buildup and congestive heart failure [16].
Furthermore, an additional improvement is the coupling of the pacemaker
and ICD system to a drug therapy device. In response to a drop in thoracic
impedance, diuretics such as furosemide or bumetanide can be administered to
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the patient to reduce this fluid buildup. These extra medical devices allow for
immediate treatment during onset of a pulmonary edema.
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Acronyms and Definitions

ICD – Implantable Cardioverter Defibrillator
CRT-D – Cardiac Resynchronization Therapy Defibrillator
PE – Pulmonary Edema
CHF – Congestive Heart Failure
HF – Heart Failure
FI – Fluid Index
MA – Moving Average
FER – False Excursion Rate
PEFDR – Percent of Event Free Duration spent in Resolution
RV – Right Ventricle (Heart Chamber)
LV – Left Ventricle (Heart Chamber)
RA – Right Atrium (Heart Chamber)
LA – Left Atrium (Heart Chamber)
RVr – Right Ventricle ring (Electrode)
LVr – Left Ventricle ring (Electrode)
RAr – Right Atrium ring (Electrode)
LAr – Left Atrium ring (Electrode)
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